kevin hughes , of canvey , essex , took part in clinical trials of abiraterone to treat his prostate cancer .
the 58-year-old has been left devastated by a decision this week by the national institute for health and care excellence -lrb- nice -rrb- not to fund the drug for patients who have not undergone chemotherapy .
mr hughes was given three years to live after being diagnosed with advanced prostate cancer last april .
the drug is currently available on the nhs to men who have already gone through chemotherapy .